These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 29905788

  • 1. Extended use of the wearable cardioverter-defibrillator in patients at risk for sudden cardiac death.
    Kutyifa V, Vermilye K, Daimee UA, McNitt S, Klein H, Moss AJ.
    Europace; 2018 Sep 01; 20(FI2):f225-f232. PubMed ID: 29905788
    [Abstract] [Full Text] [Related]

  • 2. Sex differences in arrhythmic burden with the wearable cardioverter-defibrillator.
    Goldenberg I, Erath JW, Russo AM, Burch AE, Assmus B, Bonderman D, McNitt S, Kutyifa V.
    Heart Rhythm; 2021 Mar 01; 18(3):404-410. PubMed ID: 33248269
    [Abstract] [Full Text] [Related]

  • 3. The US Experience of the Wearable Cardioverter-Defibrillator in Pediatric Patients.
    Spar DS, Bianco NR, Knilans TK, Czosek RJ, Anderson JB.
    Circ Arrhythm Electrophysiol; 2018 Jul 01; 11(7):e006163. PubMed ID: 29945928
    [Abstract] [Full Text] [Related]

  • 4. Experience with the wearable cardioverter-defibrillator in older patients: Results from the Prospective Registry of Patients Using the Wearable Cardioverter-Defibrillator.
    Daimee UA, Vermilye K, Moss AJ, Goldenberg I, Klein HU, McNitt S, Zareba W, Kutyifa V.
    Heart Rhythm; 2018 Sep 01; 15(9):1379-1386. PubMed ID: 29678779
    [Abstract] [Full Text] [Related]

  • 5. Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Kutyifa V, Moss AJ, Klein H, Biton Y, McNitt S, MacKecknie B, Zareba W, Goldenberg I.
    Circulation; 2015 Oct 27; 132(17):1613-9. PubMed ID: 26316618
    [Abstract] [Full Text] [Related]

  • 6. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA, Koneru JN, Sharma PS, Deshpande S, Wan C, Szymkiewicz SJ.
    JACC Clin Electrophysiol; 2017 Mar 27; 3(3):243-250. PubMed ID: 29759518
    [Abstract] [Full Text] [Related]

  • 7. Outcome of Patients With In-Hospital Ventricular Tachycardia and Ventricular Fibrillation Arrest While Using a Wearable Cardioverter Defibrillator.
    Ellenbogen KA, Wan C, Shavelle DM.
    Am J Cardiol; 2018 Jan 15; 121(2):205-209. PubMed ID: 29153771
    [Abstract] [Full Text] [Related]

  • 8. First human safety and effectiveness study of defibrillation with a novel patch wearable cardioverter-defibrillator.
    Chovanec M, Petrů J, Hála P, Kralovec S, Thakkar AB, Mathews K, Dinger M, Ullery S, Eapen ZJ, Kumar UN, Neužil P.
    Europace; 2024 Jul 02; 26(7):. PubMed ID: 39001864
    [Abstract] [Full Text] [Related]

  • 9. The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients.
    Erath JW, Vamos M, Sirat AS, Hohnloser SH.
    Clin Res Cardiol; 2017 Apr 02; 106(4):300-306. PubMed ID: 27888304
    [Abstract] [Full Text] [Related]

  • 10. Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in Switzerland.
    Kovacs B, Reek S, Saguner AM, Krasniqi N, Eriksson U, Duru F.
    Swiss Med Wkly; 2019 Nov 04; 149():w20136. PubMed ID: 31707723
    [Abstract] [Full Text] [Related]

  • 11. A wearable cardioverter defibrillator with a low false alarm rate.
    Poole JE, Gleva MJ, Birgersdotter-Green U, Branch KRH, Doshi RN, Salam T, Crawford TC, Willcox ME, Sridhar AM, Mikdadi G, Beinart SC, Cha YM, Russo AM, Rowbotham RK, Sullivan J, Gustavson LM, Kivilaid K.
    J Cardiovasc Electrophysiol; 2022 May 04; 33(5):831-842. PubMed ID: 35174572
    [Abstract] [Full Text] [Related]

  • 12. One-year follow-up of the prospective registry of patients using the wearable defibrillator (WEARIT-II Registry).
    Kutyifa V, Moss AJ, Klein HU, McNitt S, Zareba W, Goldenberg I.
    Pacing Clin Electrophysiol; 2018 Oct 04; 41(10):1307-1313. PubMed ID: 29992590
    [Abstract] [Full Text] [Related]

  • 13. Prior history of atrial fibrillation and arrhythmic outcomes: Data from the WEARIT-II prospective registry.
    Goldenberg I, Younis A, McNitt S, Klein H, Goldenberg I, Kutyifa V.
    J Cardiovasc Electrophysiol; 2024 Apr 04; 35(4):785-793. PubMed ID: 38383981
    [Abstract] [Full Text] [Related]

  • 14. Incidence of and predictors for appropriate implantable cardioverter-defibrillator therapy in patients with a secondary preventive implantable cardioverter-defibrillator indication.
    Schaer B, Kühne M, Reichlin T, Osswald S, Sticherling C.
    Europace; 2016 Feb 04; 18(2):227-31. PubMed ID: 26063686
    [Abstract] [Full Text] [Related]

  • 15. Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
    Röger S, Rosenkaimer SL, Hohneck A, Lang S, El-Battrawy I, Rudic B, Tülümen E, Stach K, Kuschyk J, Akin I, Borggrefe M.
    BMC Cardiovasc Disord; 2018 Mar 15; 18(1):52. PubMed ID: 29544442
    [Abstract] [Full Text] [Related]

  • 16. Potential roles of the wearable cardioverter-defibrillator in acute phase care of patients at high risk of sudden cardiac death: A single-center Japanese experience.
    Sasaki S, Shoji Y, Ishida Y, Kinjo T, Tsushima Y, Seno M, Nishizaki F, Itoh T, Izumiyama K, Yokota T, Yokoyama H, Yamada M, Horiuchi D, Kimura M, Higuma T, Tomita H, Okumura K.
    J Cardiol; 2017 Jan 15; 69(1):359-363. PubMed ID: 27595899
    [Abstract] [Full Text] [Related]

  • 17. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM, Kutyifa V, Arshad A, McNitt S, Polonsky B, Wang PJ, Moss AJ, Zareba W.
    J Cardiovasc Electrophysiol; 2015 Aug 15; 26(8):862-871. PubMed ID: 25929699
    [Abstract] [Full Text] [Related]

  • 18. Wearable Cardioverter-Defibrillators following Cardiac Surgery-A Single-Center Experience.
    Heimeshoff J, Merz C, Ricklefs M, Kirchhoff F, Haverich A, Bara C, Kühn C.
    Thorac Cardiovasc Surg; 2019 Mar 15; 67(2):92-97. PubMed ID: 29925094
    [Abstract] [Full Text] [Related]

  • 19. Use of the wearable cardioverter-defibrillator (WCD) and WCD-based remote rhythm monitoring in a real-life patient cohort.
    Zylla MM, Hillmann HAK, Proctor T, Kieser M, Scholz E, Zitron E, Katus HA, Thomas D.
    Heart Vessels; 2018 Nov 15; 33(11):1390-1402. PubMed ID: 29721674
    [Abstract] [Full Text] [Related]

  • 20. The impact of wearable cardioverter-defibrillator use on long-term decision for implantation of a cardioverter-defibrillator in a semirural acute care hospital.
    Sinha AM, Bense J, Hohenforst-Schmidt W.
    J Interv Card Electrophysiol; 2021 Nov 15; 62(2):401-407. PubMed ID: 33200285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.